![](/img/cover-not-exists.png)
Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis:post hocanalyses of the EPOC trial
Calkwood, Jonathan, Cree, Bruce, Crayton, Heidi, Kantor, Daniel, Steingo, Brian, Barbato, Luigi, Hashmonay, Ron, Agashivala, Neetu, McCague, Kevin, Tenenbaum, Nadia, Edwards, KeithVolume:
14
Language:
english
Journal:
BMC Neurology
DOI:
10.1186/s12883-014-0220-1
Date:
December, 2014
File:
PDF, 566 KB
english, 2014